// company-profile

BioCardia, Inc.

BCDA
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings103Insiders13
// api This BioCardia, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 3 insiders purchased shares (net $6K). Buying was led by Altman Peter.

// 90-day insight

Over the last 90 days, BioCardia, Inc. insiders bought $25K across 10 transactions with no open-market sales.

  • Most active insider: Altman Peter with 10 transactions totaling $25K.
  • Largest single purchase: $6K by Altman Peter on Apr 29, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of BioCardia, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$725,649
QoQ change
-9.1%
Reporting period
2026-03-31
#1
CM Management, LLC
CIK 1841857
$157,300
130K shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$150,755
125K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
CIK 1214717
$90,649
75K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 18, 2026Altman PeterBCDA
Purchase
800$0.96$1K
Jun 17, 2026Altman PeterBCDA
Purchase
1,500$0.85$1K
Jun 9, 2026Altman PeterBCDA
Purchase
5,000$0.85$4K
May 20, 2026Altman PeterBCDA
Purchase
1,500$0.92$1K
May 19, 2026Altman PeterBCDA
Purchase
200$0.95$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.